What are the risks and recovery expectations?

TAF is well-tolerated, with mild side effects such as nausea, headache, or fatigue in the first few weeks. Serious risks are rare but include kidney toxicity and decreased bone mineral density with long-term use; quarterly monitoring helps detect these early. Recovery is not applicable because this is an ongoing maintenance therapy—patients continue daily tablets indefinitely. Most people resume normal activities immediately, with no downtime.